|

Olanzapine Clinical Trials

8 actively recruiting trials across 3 locations

▼ -1 trial since August 2026

Also known as: LY 170053, Zyprexa, Zyprexa Zydis, Zypreza

Pipeline

Phase 2: 3Phase 3: 3Phase 1/2: 1

Top Sponsors

  • The Affiliated People's Hospital of Ningbo University1
  • Second Affiliated Hospital of Nanchang University1
  • Roswell Park Cancer Institute1
  • OHSU Knight Cancer Institute1
  • First Affiliated Hospital of Chongqing Medical University1

Indications

Other5 trials

Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors
N/A
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
Phase 2
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
Phase 3
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2
The Danish Out-of-Hospital Cardiac Arrest Study
Phase 3

Augusta, Georgia1 trial

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Wellstar MCG

Phase 3

Buffalo, New York1 trial

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Roswell Park Cancer Institute

Phase 2

Portland, Oregon1 trial

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

OHSU Knight Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.